Thermal ablation versus hepatic resection for colorectal cancer with synchronous liver metastases: a propensity score matching study
- PMID: 35999370
- DOI: 10.1007/s00330-022-09080-z
Thermal ablation versus hepatic resection for colorectal cancer with synchronous liver metastases: a propensity score matching study
Abstract
Objectives: Several studies have compared the efficacy of hepatic resection (HR) and thermal ablation (TA) for unresectable tumors; however, results remain inconsistent. Most cohorts in previous studies were heterogeneous groups of synchronous colorectal liver metastases (CRLM) and extrahepatic metastases. This retrospective study aimed to compare the therapeutic efficacy between TA and HR in synchronous CRLM without extrahepatic metastases.
Methods: Cases with initially synchronous CRLM without extrahepatic metastases between January 2007 and December 2018 were enrolled. Of the 448 cases, 346 received HR and 102 TA. Propensity score matching with a 1:1 ratio was used to improve the comparability between the HR and TA groups. Technical success, complications, disease-free survival (DFS), and overall survival (OS) were compared before and after matching.
Results: All patients achieved technical success. Major complication rates in the HR and TA groups were, respectively, 36.7% and 8.8% (p < 0.001). Before matching, the 5-year OS and DFS (p = 0.004 and p = 0.020, respectively) were significantly higher in the HR group than in the TA group. After matching, no significant difference in the 5-year OS and DFS was found between the groups (p = 0.770 and p = 0.939, respectively). Local tumor progression rate was significantly higher in the TA group both before (p = 0.027) and after (p = 0.029) matching.
Conclusions: For patients with CRC with synchronous CRLM, TA and HR provide comparable OS and DFS. TA is preferable if complete ablation is predicted.
Key points: • Thermal ablation and hepatic resection provide comparable overall survival and disease-free survival. • Thermal ablation is a safe and effective treatment for patients with colorectal cancer with synchronous liver metastases and has a lower major complication rate and higher repeatability than hepatic resection. • Thermal ablation is preferable if complete ablation is predicted.
Keywords: Colorectal cancer; Liver metastases; Prognosis; Synchronous; Thermal ablation.
© 2022. The Author(s), under exclusive licence to European Society of Radiology.
Similar articles
-
[Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Oct 25;23(10):976-983. doi: 10.3760/cma.j.cn.441530-20200414-00204. Zhonghua Wei Chang Wai Ke Za Zhi. 2020. PMID: 33053993 Chinese.
-
Significance of postoperative adjuvant chemotherapy with an oxaliplatin-based regimen after simultaneous curative resection for colorectal cancer and synchronous colorectal liver metastasis: a propensity score matching analysis.BMC Surg. 2021 Apr 9;21(1):188. doi: 10.1186/s12893-021-01193-4. BMC Surg. 2021. PMID: 33836701 Free PMC article.
-
Propensity score matching demonstrates similar results for radiofrequency ablation compared to surgical resection in colorectal liver metastases.Eur J Surg Oncol. 2022 Jun;48(6):1368-1374. doi: 10.1016/j.ejso.2022.01.008. Epub 2022 Jan 17. Eur J Surg Oncol. 2022. PMID: 35078702
-
The prognosis of radiofrequency ablation versus hepatic resection for patients with colorectal liver metastases: A systematic review and meta-analysis based on 22 studies.Int J Surg. 2021 Mar;87:105896. doi: 10.1016/j.ijsu.2021.105896. Epub 2021 Feb 12. Int J Surg. 2021. PMID: 33588125
-
[Hepatic metastasis of colorectal cancer--current therapeutic possibilities].Chirurgia (Bucur). 2010 Mar-Apr;105(2):155-69. Chirurgia (Bucur). 2010. PMID: 20540227 Review. Romanian.
Cited by
-
End of the Long Road or First Chapter of a New Story: Clinical Reflections on the COLLISION Trial.Cardiovasc Intervent Radiol. 2025 Aug;48(8):1088-1090. doi: 10.1007/s00270-025-04110-x. Epub 2025 Jul 10. Cardiovasc Intervent Radiol. 2025. PMID: 40640412 No abstract available.
-
Sorafenib with or without co-interventions for hepatocellular carcinoma.Cochrane Database Syst Rev. 2025 Jun 26;6(6):CD015851. doi: 10.1002/14651858.CD015851. Cochrane Database Syst Rev. 2025. PMID: 40568833 Free PMC article. Review.
-
Survival after combined resection and ablation is not inferior to that after resection alone, in patients with four or more colorectal liver metastases.Langenbecks Arch Surg. 2023 Aug 29;408(1):343. doi: 10.1007/s00423-023-03082-1. Langenbecks Arch Surg. 2023. PMID: 37642753 Free PMC article.
References
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424 - PubMed
-
- Gillams A, Goldberg N, Ahmed M et al (2015) Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, The Interventional Oncology Sans Frontières meeting 2013. Eur Radiol 25:3438–3454 - DOI
-
- Engstrand J, Nilsson H, Strömberg C, Jonas E, Freedman J (2018) Colorectal cancer liver metastases - a population-based study on incidence, management and survival. BMC Cancer 18:78 - DOI
-
- Elias D, Viganò L, Orsi F et al (2016) New perspectives in the treatment of colorectal metastases. Liver Cancer 6:90–98 - DOI
-
- Ahmed M, Brace CL, Lee FT Jr, Goldberg SN (2011) Principles of and advances in percutaneous ablation. Radiology 258:351–369 - DOI
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical